CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,827 enrolled
Drug / intervention
HRMEother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04472455
NCT04472455N/ACompleted
CompareCT.gov

Mobile High-Resolution Microendoscopy (mHRME) for the Detection of Cervical Dysplasia in El Salvador

William Marsh Rice University·observational·Posted Jul 15, 2020·Updated Jul 15, 2020

In Brief

An observational study evaluating HRME for Cervical Cancer. Completed, enrolled 1,827 participants.

Detailed Summary

Evaluate the performance of the mHRME in a study of 3,000 women in San Salvador to assess whether mHRME imaging improves specificity of screening by VIA or HPV DNA without reducing sensitivity for cervical precancer and cancer.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Cancer
Countries--
CollaboratorsBasic Health International, Inc., M.D. Anderson Cancer Center, Albert Einstein College of Medicine, The Cleveland Clinic

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 15, 2020
Enrollment StartSep 1, 2015
Primary CompletionApr 2, 2019
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 6.0 years ago

Interventions

HRMEother